Small Cell Ovarian Cancer Causing Acute Kidney Injury
This ovarian cancer diagnosis at a glance
- Stage at diagnosis
- Stage III
- Subtype
- Small Cell Lung Cancer
- Biomarkers
- Somatic SMARCA4 alterations; no germline SMARCA4 pathogenic variant
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation and immunotherapy
- Outcome
- Responding Well
Treatment course, step by step
- She underwent emergency tumor-reduction surgery, then received 6 cycles of carboplatin and etoposide, with bleomycin added.
- After progression, she received 2 courses of radiation and pembrolizumab with carboplatin and paclitaxel.
- Imaging showed an excellent response after 13 cycles.
What happened, in summary
A woman in her mid-30s developed abdominal pain and bloating over 3 weeks, followed by fever, nausea, urinary symptoms, and rapidly worsening kidney function. Imaging found a large pelvic mass, and the kidney injury did not improve with standard measures. With ovarian cancer strongly suspected and her condition deteriorating, a multidisciplinary team performed emergency cytoreductive surgery. The operation included ureteric stents, drainage of ascites, hysterectomy, removal of both ovaries and fallopian tubes, omentectomy, para-aortic lymph-node dissection, and excision of bladder peritoneum. No visible tumor remained.
Pathology showed stage IIIC small cell carcinoma of the ovary, hypercalcaemic type, involving the left ovary, left fallopian tube, and 11 of 18 para-aortic lymph nodes. Tumor testing found somatic SMARCA4 alterations but no germline SMARCA4 pathogenic variant. Kidney function improved within hours of surgery, supporting a cancer-related paraneoplastic cause.
She began carboplatin and etoposide, with bleomycin added for 3 cycles. Disease progressed after 6 first-line cycles. She then received 30 Gy of radiation in 10 fractions with pembrolizumab, carboplatin, and paclitaxel. A mixed response led to a second 30 Gy course in 10 fractions. Treatment continued, and imaging after 13 cycles showed an excellent response.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 3 Ovarian Cancer 35 stories
- Carboplatin for Ovarian Cancer 58 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer